Generic equivalent of Buprenorphine and Naloxone
2 SKUs available · Available to order · NABP accredited · DSCSA compliant
Buprenorphine and naloxone is the generic equivalent of the brand-name drug Buprenorphine and Naloxone. Licensed pharmacies, clinics, doctor's offices, and veterinary practices can source wholesale Buprenorphine and naloxone through Premier Pharma with same-day fulfillment on in-stock SKUs.
1 INDICATIONS AND USAGE Buprenorphine and naloxone sublingual tablet is indicated for the maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablet should be used as part of a complete treatment plan that includes counseling and psychosocial support. Buprenorphine and naloxone sublingual tablet contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence. ( 1 ) Buprenorphine and naloxone sublingual tablet should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )
6 ADVERSE REACTIONS The following serious adverse reactions are described elsewhere in the labeling: Addiction, Abuse, and Misuse [see Warnings and Precautions (5.1)] Respiratory and CNS Depression [see Warnings and Precautions (5.2, 5.3)] Neonatal Opioid Withdrawal Syndrome [see Warnings and Precautions (5.5)] Adrenal Insufficiency [see Warnings and Precautions (5.6)] Opioid Withdrawal [see Warnings and Precautions (5.7, 5.10)] Hepatitis, Hepatic Events [see Warnings and Precautions (5.8)] Hype…
7 DRUG INTERACTIONS Table 3 Includes clinically significant drug interactions with buprenorphine and naloxone sublingual tablets Table 3. Clinically Significant Drug Interactions with Buprenorphine and Naloxone Sublingual Tablets Benzodiazepines or other Central Nervous System (CNS) Depressants Clinical Impact: Due to additive pharmacologic effects, the concomitant use of benzodiazepines or other CNS depressants, including alcohol, can increase the risk of hypotension, respiratory depression, pr…
2 DOSAGE AND ADMINISTRATION Administer buprenorphine and naloxone sublingual tablet sublingually as a single daily dose. (2.1) Strongly consider recommending or prescribing an opioid overdose reversal agent (e.g., naloxone, nalmefene) at the time buprenorphine and naloxone sublingual tablets are initiated or renewed because patients being treated for opioid use disorder have the potential for relapse, putting them at risk for opioid overdose. (2.2) To avoid precipitating withdrawal, induction wi…
17 PATIENT COUNSELING INFORMATION Advise patients to read the FDA-approved patient labeling (Medication Guide). Storage and Disposal Because of the risks associated with accidental ingestion, misuse, and abuse, advise patients to store buprenorphine and naloxone sublingual tablets securely, out of sight and reach of children, and in a location not accessible by others, including visitors to the home [see Warnings and Precautions (5.1, 5.4), Drug Abuse and Dependence (9.2)]. Inform patients that leaving buprenorphine and naloxone sublingual tablets unsecured can pose a deadly risk to others in…
Source: FDA. For professional use only. Not a substitute for prescribing information.
| Name | Status |
|---|---|
| BUPRENORPHINE AND NALOXONE SUBLINGUAL 2 MG / 0.5 MG 30 TAB | 2-Day |
| BUPRENORPHINE AND NALOXONE SUBLINGUAL 8 MG / 2 MG 30 TAB | 2-Day |
Premier Pharma stocks 2 Buprenorphine and naloxone SKUs — 0 currently in stock — available to licensed pharmacies, clinics, doctor's offices, and veterinary practices. Buprenorphine and naloxone is the generic equivalent of Buprenorphine and Naloxone. Create a free account to see live wholesale pricing and place orders with same-day fulfillment for in-stock items.
Premier Pharma carries Buprenorphine and naloxone in 2 mg/1, .5 mg/1, 8 mg/1, 2 mg/1 and TABLET.
Create a free Premier Pharma account to unlock live wholesale pricing, place orders, and track shipments — approval typically takes minutes for licensed pharmacies, clinics, doctor's offices, and veterinary practices.